BACKGROUND: Little research is available comparing differences in cancer risk perceptions between cancer survivors and family members at risk for hereditary breast/ovarian cancer. METHODS: Qualitative focus groups with survivor-female relative dyads (N = 39) were conducted. RESULTS: Important differences exist between the concerns of survivors and family members relevant to their cancer risk. Survivors focused on their own concerns from a personal perspective, whereas family members focused on the survivors' health and tended to suppress their own fears of cancer. Specific recommendations for inclusion of family members in cancer risk education are provided. CONCLUSIONS: Addressing family member differences is critical to tailor specific risk information inclusive of the entire family.
BACKGROUND: Little research is available comparing differences in cancer risk perceptions between cancer survivors and family members at risk for hereditary breast/ovarian cancer. METHODS: Qualitative focus groups with survivor-female relative dyads (N = 39) were conducted. RESULTS: Important differences exist between the concerns of survivors and family members relevant to their cancer risk. Survivors focused on their own concerns from a personal perspective, whereas family members focused on the survivors' health and tended to suppress their own fears of cancer. Specific recommendations for inclusion of family members in cancer risk education are provided. CONCLUSIONS: Addressing family member differences is critical to tailor specific risk information inclusive of the entire family.
Authors: J M Satagopan; K Offit; W Foulkes; M E Robson; S Wacholder; C M Eng; S E Karp; C B Begg Journal: Cancer Epidemiol Biomarkers Prev Date: 2001-05 Impact factor: 4.254
Authors: J P Struewing; P Hartge; S Wacholder; S M Baker; M Berlin; M McAdams; M M Timmerman; L C Brody; M A Tucker Journal: N Engl J Med Date: 1997-05-15 Impact factor: 91.245
Authors: S Appleton; M Watson; R Rush; S Garcia-Minaur; M Porteous; J Campbell; E Anderson; A Cull Journal: Br J Cancer Date: 2004-01-12 Impact factor: 7.640